Company Overview
| Stock Name | Joyzyme Group |
|---|---|
| Stock Code | 08622 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 本集團專注於在中國研發、生產及銷售男性不育、寄生蟲系列及EB病毒等體外診斷試劑,並銷售輔助生育用品和設備。 |
| Listing Date | 2018-12-13 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國深圳市大鵬新區葵涌街道葵新社區銀葵路16號深圳君軒D棟一至三層 |
| Business Address (Hong Kong) | 香港中環德輔道中100號2樓 |
| Place of Incorporation | 開曼群島 |
| Listing Method | 發售以供認購 + 發售以供配售 |
| Listing Board | GEM |
| Website | www.szhuakang.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 0.50 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | 2018-11-30 to 2018-12-05 |
| Global Offering Shares | 100,000,000 shares |
| HK Public Offer Shares (Initial) | 10,000,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 90,000,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 400,000,000 shares |
| Greenshoe (Over-allotment Option) | No |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 50,000,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| HK Market Cap | HK$ 139.4M |
| Est. Threshold | HK$ 9.39B |
| Analysis Result | HK market cap below threshold, need +6637% |
Valuation & Financials
| Market Cap (at Offer Price) | HK$ 200,000,000 |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | 不適用(公司處於虧損狀態) |
| Profit/Loss Status | 虧損人民幣1.95百萬元 |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | ~HK$ 33,800,000 |
| Listing Expenses / Funds Raised | ~67.6% |
| Total Pre-IPO Investment | 港元20.0百萬元 |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2015 | 2016 | 2017 | 2018-05 |
|---|---|---|---|---|
| Revenue | 19,456 | 25,410 | 26,541 | 11,012 |
| Cost of sales | -5,088 | -7,788 | -8,007 | -2,841 |
| Gross profit | 14,368 | 17,622 | 18,534 | 8,171 |
| Other income and gains, net | 2,062 | -1,140 | 860 | 135 |
| Selling and distribution expenses | -2,734 | -2,910 | -2,860 | -1,297 |
| Administrative expenses | -1,565 | -2,290 | -3,244 | -1,776 |
| Operating profit | 10,487 | 10,072 | -193 | 2,198 |
| Net finance costs | -1,284 | -128 | -54 | 0 |
| Profit before tax | 9,203 | 9,944 | -247 | 2,198 |
| Income tax expense | -1,269 | -1,518 | -1,705 | -728 |
| Profit for the year | 7,934 | 8,426 | -1,952 | 1,470 |
| Profit attributable to owners | 7,934 | 8,426 | -1,952 | 1,470 |
Balance Sheet
| Item | 2015 | 2016 | 2017 | 2018-05 |
|---|---|---|---|---|
| Cash and cash equivalents | 6,093 | 15,914 | 19,811 | 17,814 |
| Trade and bills receivables | 7,368 | 9,414 | 9,848 | 11,388 |
| Inventories | 2,381 | 2,408 | 1,945 | 1,851 |
| Total current assets | 19,621 | 29,782 | 35,915 | 36,162 |
| Total assets | 27,488 | 37,448 | 48,422 | 49,745 |
| Total current liabilities | 10,463 | 12,632 | 10,812 | 10,684 |
| Total liabilities | 11,713 | 13,247 | 11,032 | 10,885 |
| Total equity | 15,775 | 24,201 | 37,390 | 38,860 |
| Equity attributable to owners | 15,775 | 24,201 | 37,390 | 38,860 |
| Interest-bearing borrowings | 1,550 | 950 | 0 | 0 |
Cash Flow Statement
| Item | 2015 | 2016 | 2017 | 2018-05 |
|---|---|---|---|---|
| Net cash from operating activities | 5,455 | 11,255 | 2,699 | 57 |
| Net cash from investing activities | 6,246 | -1,569 | -4,380 | -1,735 |
| Net cash from financing activities | -9,131 | 135 | 5,578 | -319 |
| Net increase in cash | 2,570 | 9,821 | 3,897 | -1,997 |
| Depreciation of PP&E | 478 | 606 | 1,071 | 532 |
| Amortisation of intangible assets | 33 | 302 | 351 | 146 |
| Purchase of PP&E | -2,613 | -2,057 | -4,154 | -15 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 0.47 |
|---|---|
| First Day Open | HK$ 0.495 |
| First Day Change | -6.00% |
| First Day Volume | 125728000.0 |
| First Day Turnover | 64066800.0 |
| Use of Proceeds | 1、所得款項凈額41.5%(或6.9百萬港元)將用于開發新產品、改良我們的現有產品及開展國際合作項目;
2、所得款項凈額27.3%(或4.5百萬港元)將用于擴展我們的銷售網絡以及加強我們的銷售及營銷活動;
3、所得款項凈額27.9%(或4.6百萬港元)將用于發展輔助生育用品業務;
4、所得款項凈額3.3%(或548,000港元)將用于為營運資金撥付資金。 |
Underwriting Syndicate
Sole Sponsor (1)
RHB Capital Hong Kong Limited CE AGC194
Joint Bookrunners (2)
Joint Lead Managers (3)
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 張曙光 | — |
| Company Secretary | 周麗麒 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 張曙光先生(透過Crystal Grant)持有36.14%權益,張賢陽先生(透過Ever Charming)持有23.86%權益,合共60%,被視為一組控股股東。 |
|---|




